Kyaresta 1mg (Anastrozole) – 28 Tablets | Aromatase Inhibitor for Breast Cancer Treatment

Effective Hormonal Therapy for Postmenopausal Breast Cancer Patients

Kyaresta 1mg Tablets contain Anastrozole, a potent aromatase inhibitor used primarily to treat hormone receptor-positive breast cancer in postmenopausal women. By reducing estrogen levels in the body, Kyaresta slows or stops the growth of estrogen-dependent breast tumors, making it a standard in hormonal cancer therapy.

What Is Kyaresta Used For?

• ✅ Treatment of early and advanced-stage breast cancer in postmenopausal women

• ✅ Hormonal therapy alternative to tamoxifen

• ✅ Supports long-term cancer remission strategies

• ✅ Often used after surgery or radiation to prevent cancer recurrence

How Does Kyaresta (Anastrozole) Work?

Kyaresta works by inhibiting aromatase, an enzyme responsible for converting androgens into estrogens. By blocking this conversion, anastrozole significantly lowers estrogen levels in the body, which is essential for slowing down or halting the progression of estrogen-sensitive breast cancers.

Who Should NOT Take Kyaresta?

Do not take Kyaresta if:

• You are pregnant or breastfeeding

• You have not yet reached menopause

• You suffer from severe liver or kidney impairment

• You are allergic to anastrozole or any of the excipients

• You are taking estrogen-containing medications or tamoxifen

Dosage and Directions for Use

• 💊 Recommended Dose: 1 tablet (1mg) once daily, preferably at the same time each day

• 💧 Swallow with water, with or without food

• 🔁 Treatment duration is typically 5 years, or as directed by your oncologist

• 🔁 Do not skip or stop treatment unless instructed by your doctor

Kyaresta and Osteoporosis – Bone Health Matters

Because Kyaresta reduces estrogen, it can contribute to bone mineral density loss. Patients should undergo DEXA scans regularly and may require preventive osteoporosis treatments such as calcium, vitamin D, or bisphosphonates.

Possible Side Effects of Kyaresta Tablets

🔹 Very Common (≥1 in 10)

• Facial flushing

• Joint or muscle pain

• Vaginal dryness

🔹 Common (1 in 10 to 1 in 100)

• Weakness, fatigue

• Headaches, dizziness

• Nausea, diarrhea

• Rash or hair thinning

• Carpal tunnel syndrome

• Elevated liver enzymes

🔹 Rare but Serious

• Severe allergic reactions (swelling, rash, anaphylaxis)

• Stevens-Johnson Syndrome

• Hepatitis or liver dysfunction

📌 Contact your doctor immediately if you experience any unusual symptoms.

Interactions to Avoid

• ❌ Do not take with Tamoxifen or Estrogen supplements – they reduce Kyaresta’s effectiveness

• ⚠️ No data is available for use with LHRH analogues (e.g., goserelin) outside of clinical trials

• 📋 Always disclose any other medications you’re taking, including over-the-counter and herbal supplements

Storage Guidelines

• 📦 Store below 30°C

• 🚫 Keep out of reach of children

• 🗑 Do not dispose of in household waste – ask your pharmacist how to properly discard unused tablets

Product Details

• 🧪 Active Ingredient: Anastrozole 1 mg

• 💊 Tablet Count: 28 film-coated tablets per pack

• 📋 Other Ingredients: Lactose monohydrate, povidone, magnesium stearate, titanium dioxide, etc.

• 📅 Shelf Life: See expiry date on packaging

Why Choose Kyaresta 1mg Tablets?

• ✔ Clinically proven to support breast cancer remission

• ✔ Recommended as a first-line therapy in postmenopausal hormone-receptor-positive breast cancer

• ✔ Long track record of safety and effectiveness in oncology care